Skip to content

Effect of Adding Scapulothoracic Stabilization Exercises to Dorsal Scapular Nerve Blockade in Patients with Nerve Entrapment Syndrome.

Effect of Adding Scapulothoracic Stabilization Exercises to Dorsal Scapular Nerve Blockade in Patients with Nerve Entrapment Syndrome: A single-blinded randomized controlled trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
PACTR
Registry ID
PACTR202402720946459
Enrollment
70
Registered
2024-02-02
Start date
2023-05-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal Diseases Nervous System Diseases

Interventions

Dorsal Scapular Nerve Blockade Injection
Additional Scapulothoracic stabilization exercises to the dorsal scapular nerve blockade injection

Sponsors

Bassam El Nassag
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - patients ranging in age from 20 to 60 years old. - All patients must have had chronic pain in the interscapular region and/or radiating to the neck or shoulder region, and the pain should be for at least 3 months duration. - The pain intensity should be at least 5/10 on a 10-point Numeric Rating Scale (NRS) (where 0 means no pain and 10 is the worst pain imaginable) and have failed medical treatment. - Patients with motor symptoms secondary to the DSC entrapment, such as winged scapula, weak scapular adductors, and scapula dyskinesis, could be included.

Exclusion criteria

Exclusion criteria: - Patients with a history of coagulopathy or other bleeding disorders. - Patients with a history of neuromuscular disorders, and cervical radiculopathy. - Patients having a history of allergy to local anesthetics, and administration of any sedatives. - Patients with a history of trauma, surgery, or structural pathology in the target region. - Patients with preexisting mental illness, psychological or emotional problems, infection at the injection site, or refusal to participate in the trial were excluded.

Design outcomes

Primary

MeasureTime frame
Pain, using the Numeric Pain Rating Scale.;The Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire. It is a 30-item questionnaire that looks at the ability of a patient to perform certain upper extremity activities. It is a self-report questionnaire that patients can rate difficulty and interference with daily life on a 5-point Likert scale.

Secondary

MeasureTime frame
Motor Distal Latency for the involved Dorsal Scapular Nerve.;The Fatigue Assessment Scale. It is a 10-item scale evaluating symptoms of chronic fatigue.

Countries

Egypt

Contacts

Public ContactShaymaa Salem

Sphinx university Egypt

Drshymaasalem@yahoo.com+201005228820

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026